FRA:8SJ (China)
Â
Class H
€
1.94
-0.10 (-4.9%)
Apr 2
Warning! GuruFocus detected
5 Severe warning signs
with 8SJ.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Shanghai Junshi Biosciences Co Ltd
ISIN : CNE100003FF7
Share Class Description:
FRA:8SJ: Class HCompare
Compare
Traded in other countries / regions
01877.Hong Kong688180.China8SJ.GermanySHJBF.USA IPO Date
2022-06-24Description
Shanghai Junshi Biosciences Co Ltd is a China-based biotechnology companyy with all-round capabilities in innovative drug discovery and development, clinical research on a global scale, large-scale production capacity to commercialization on the full industry chain. Aiming to develop first-in-class or bestin-class drugs by way of original innovation and co-development. Companies operations are located in the PRC and the USA.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1 | |||||
| Equity-to-Asset | 0.54 | |||||
| Debt-to-Equity | 0.5 | |||||
| Debt-to-EBITDA | -2.21 | |||||
| Piotroski F-Score | N/A/9 | |||||
| Altman Z-Score | 2.04 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -27.4 | |||||
| 3-Year EBITDA Growth Rate | -49.7 | |||||
| 3-Year EPS without NRI Growth Rate | -7.8 | |||||
| 3-Year FCF Growth Rate | -3.2 | |||||
| 3-Year Book Growth Rate | -15.9 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 21.63 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 65.01 | |||||
| 9-Day RSI | 63.39 | |||||
| 14-Day RSI | 61.89 | |||||
| 3-1 Month Momentum % | 50.38 | |||||
| 6-1 Month Momentum % | 9.29 | |||||
| 12-1 Month Momentum % | 76.99 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.69 | |||||
| Quick Ratio | 1.46 | |||||
| Cash Ratio | 1.15 | |||||
| Days Inventory | 965.56 | |||||
| Days Sales Outstanding | 91.99 | |||||
| Days Payable | 977.76 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -2.6 | |||||
| Shareholder Yield % | -3.98 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 88.96 | |||||
| Operating Margin % | -68.14 | |||||
| Net Margin % | -67.18 | |||||
| FCF Margin % | -53.35 | |||||
| ROE % | -19.61 | |||||
| ROA % | -11.4 | |||||
| ROIC % | -16.99 | |||||
| 3-Year ROIIC % | -30.3 | |||||
| ROC (Joel Greenblatt) % | -30.63 | |||||
| ROCE % | -15.01 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 7.77 | |||||
| PB Ratio | 2.56 | |||||
| Price-to-Tangible-Book | 2.81 | |||||
| EV-to-EBIT | -21.92 | |||||
| EV-to-Forward-EBIT | -15.81 | |||||
| EV-to-EBITDA | -21.92 | |||||
| EV-to-Forward-EBITDA | -17.65 | |||||
| EV-to-Revenue | 15.03 | |||||
| EV-to-Forward-Revenue | 15.26 | |||||
| EV-to-FCF | -25.33 | |||||
| Price-to-GF-Value | 0.88 | |||||
| Earnings Yield (Greenblatt) % | -4.57 | |||||
| FCF Yield % | -3.75 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shanghai Junshi Biosciences Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 256.011 | ||
| EPS (TTM) (€) | -0.167 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 60.69 | ||
| 14-Day RSI | 61.89 | ||
| 14-Day ATR (€) | 0.098048 | ||
| 20-Day SMA (€) | 1.7115 | ||
| 12-1 Month Momentum % | 76.99 | ||
| 52-Week Range (€) | 1.06 - 2.42 | ||
| Shares Outstanding (Mil) | 984.87 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Shanghai Junshi Biosciences Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shanghai Junshi Biosciences Co Ltd Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Shanghai Junshi Biosciences Co Ltd Frequently Asked Questions
What is Shanghai Junshi Biosciences Co Ltd(FRA:8SJ)'s stock price today?
The current price of FRA:8SJ is €1.94. The 52 week high of FRA:8SJ is €2.42 and 52 week low is €1.06.
When is next earnings date of Shanghai Junshi Biosciences Co Ltd(FRA:8SJ)?
The next earnings date of Shanghai Junshi Biosciences Co Ltd(FRA:8SJ) is 2025-04-30 Est..
Does Shanghai Junshi Biosciences Co Ltd(FRA:8SJ) pay dividends? If so, how much?
Shanghai Junshi Biosciences Co Ltd(FRA:8SJ) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers